An efficient deuteration process of α-CÀ H bonds in various carbonyl-based pharmaceutical compounds has been developed. Catalytic reactions are initiated by the action of Lewis acidic B(C 6 F 5 ) 3 and D 2 O, converting a drug molecule into the corresponding boron-enolate. Ensuing deuteration of the enolate by in situ-generated D 2 O + À H then results in the formation of α-deuterated bioactive carbonyl compounds with up to > 98% deuterium incorporation.